Examining Factors Associated with Dynapenia/Sarcopenia in Patients with Schizophrenia: A Pilot Case-Control Study

Sedentary behavior in patients with schizophrenia causes muscle weakness, is associated with a higher risk of metabolic syndrome, and contributes to mortality risk. This pilot case-control study aims to examine the associated factors for dynapenia/sarcopenia in patients with schizophrenia. The participants were 30 healthy individuals (healthy group) and 30 patients with schizophrenia (patient group), who were matched for age and sex. Descriptive statistics, Welch’s t-test, cross-tabulations, adjusted residuals, Fisher’s exact probability test (extended), and/or odds ratios (ORs) were calculated. In this study, dynapenia was significantly more prevalent in patients with schizophrenia than in healthy individuals. Regarding body water, Pearson’s chi-square value was 4.41 (p = 0.04), and significantly more patients with dynapenia were below the normal range. In particular, body water and dynapenia showed a significant association, with an OR = 3.42 and 95% confidence interval [1.06, 11.09]. Notably, compared with participants of the healthy group, patients with schizophrenia were overweight, had less body water, and were at a higher risk for dynapenia. The impedance method and the digital grip dynamometer used in this study were simple and useful tools for evaluating muscle quality. To improve health conditions for patients with schizophrenia, additional attention should be paid to muscle weakness, nutritional status, and physical rehabilitation.

[1]  Hideki Nakano,et al.  Gait Characteristics of Dynapenia, Sarcopenia, and Presarcopenia in Community-Dwelling Japanese Older Women: A Cross-Sectional Study , 2022, Healthcare.

[2]  E. Wang,et al.  Physical Health Impairment and Exercise as Medicine in Severe Mental Disorders: A Narrative Review , 2022, Sports Medicine - Open.

[3]  M. Marthoenis,et al.  Investigating Body Mass Index and Body Composition in Patients with Schizophrenia: A Case-Control Study , 2022, Schizophrenia research and treatment.

[4]  Y. Kai,et al.  Usefulness of 2D Video Analysis for Evaluation of Shoulder Range of Motion during Upper Limb Exercise in Patients with Psychiatric Disorders. , 2022, The journal of medical investigation : JMI.

[5]  Bolin Li,et al.  Association Between Sarcopenia and Depressive Symptoms in Chinese Older Adults: Evidence From the China Health and Retirement Longitudinal Study , 2021, Frontiers in Medicine.

[6]  S. Çakmak,et al.  The Prevalence of Sarcopenia in Patients with Schizophrenia , 2021 .

[7]  Philip D. Harvey,et al.  Real world sedentary behavior and activity levels in patients with schizophrenia and controls: An ecological momentary assessment study. , 2021, Mental health and physical activity.

[8]  Y. Fujiwara,et al.  Sarcopenia: prevalence, associated factors, and the risk of mortality and disability in Japanese older adults , 2020, Journal of cachexia, sarcopenia and muscle.

[9]  R. Tabarés-Seisdedos,et al.  Grip Strength, Neurocognition, and Social Functioning in People WithType-2 Diabetes Mellitus, Major Depressive Disorder, Bipolar Disorder, and Schizophrenia , 2020, Frontiers in Psychology.

[10]  S. Kurose,et al.  Prevalence and risk factors of sarcopenia in community-dwelling older adults visiting regional medical institutions from the Kadoma Sarcopenia Study , 2020, Scientific Reports.

[11]  N. Ishiguro,et al.  Dynapenia and physical performance in community-dwelling elderly people in Japan , 2020, Nagoya journal of medical science.

[12]  L. Peng,et al.  Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. , 2020, Journal of the American Medical Directors Association.

[13]  Philip D. Harvey,et al.  Cognition and disability in schizophrenia: cognition‐related skills deficits and decision‐making challenges add to morbidity , 2019, World psychiatry : official journal of the World Psychiatric Association.

[14]  C. Cooper,et al.  Sarcopenia: revised European consensus on definition and diagnosis , 2019, Age and ageing.

[15]  René Rizzoli,et al.  Sarcopenia: revised European consensus on definition and diagnosis , 2018, Age and ageing.

[16]  Yuichiro Yamada,et al.  Importance of physical evaluation using skeletal muscle mass index and body fat percentage to prevent sarcopenia in elderly Japanese diabetes patients , 2018, Journal of diabetes investigation.

[17]  E. Ferriolli,et al.  Prevalence and factors associated with sarcopenia and dynapenia in elderly people , 2018, Journal of frailty, sarcopenia and falls.

[18]  Shen Zhou,et al.  [Human Body Water Composition Measurement:Methods and Clinical Application]. , 2018, Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae.

[19]  Norio Sugawara,et al.  Prevalence of underweight in patients with schizophrenia: A meta-analysis , 2017, Schizophrenia Research.

[20]  L. Donini,et al.  Sufficient levels of 25-hydroxyvitamin D and protein intake required to increase muscle mass in sarcopenic older adults - The PROVIDE study. , 2017, Clinical nutrition.

[21]  Hajime Hasegawa,et al.  Protein Energy Wasting and Sarcopenia in Dialysis Patients. , 2018, Contributions to nephrology.

[22]  Joseph Firth,et al.  Sedentary behavior and physical activity levels in people with schizophrenia, bipolar disorder and major depressive disorder: a global systematic review and meta‐analysis , 2017, World psychiatry : official journal of the World Psychiatric Association.

[23]  Shigeho Tanaka,et al.  Developing and Validating an Age-Independent Equation Using Multi-Frequency Bioelectrical Impedance Analysis for Estimation of Appendicular Skeletal Muscle Mass and Establishing a Cutoff for Sarcopenia , 2017, International journal of environmental research and public health.

[24]  C. Galletly Premature death in schizophrenia: bridging the gap. , 2017, The lancet. Psychiatry.

[25]  S. Mathur,et al.  Muscle analysis using pQCT, DXA and MRI. , 2016, European journal of radiology.

[26]  Norio Sugawara,et al.  High prevalence of underweight and undernutrition in Japanese inpatients with schizophrenia: a nationwide survey , 2015, BMJ Open.

[27]  D. Vancampfort,et al.  Weight gain and obesity in schizophrenia: epidemiology, pathobiology, and management , 2015, Acta psychiatrica Scandinavica.

[28]  C. Hsiung,et al.  The impacts of sarcopenia and obesity on physical performance in the elderly. , 2015, Obesity research & clinical practice.

[29]  D. Henderson,et al.  Pathophysiological mechanisms of increased cardiometabolic risk in people with schizophrenia and other severe mental illnesses. , 2015, The lancet. Psychiatry.

[30]  G. Biolo,et al.  Muscle contractile and metabolic dysfunction is a common feature of sarcopenia of aging and chronic diseases: from sarcopenic obesity to cachexia. , 2014, Clinical nutrition.

[31]  O. Andreassen,et al.  Increased Mortality in Schizophrenia Due to Cardiovascular Disease – A Non-Systematic Review of Epidemiology, Possible Causes, and Interventions , 2014, Front. Psychiatry.

[32]  Marco Paoloni,et al.  Clinical definition of sarcopenia. , 2014, Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases.

[33]  Philip D. Harvey,et al.  Physical performance and disability in schizophrenia , 2014, Schizophrenia Research: Cognition.

[34]  D. Schoepf,et al.  Physical comorbidity and its relevance on mortality in schizophrenia: a naturalistic 12-year follow-up in general hospital admissions , 2014, European Archives of Psychiatry and Clinical Neuroscience.

[35]  J. Guralnik,et al.  Designing pharmaceutical trials for sarcopenia in frail older adults: EU/US task force recommendations , 2013, The journal of nutrition, health & aging.

[36]  M. Cesari,et al.  Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group. , 2013, Journal of the American Medical Directors Association.

[37]  Rachél Nilwik,et al.  The decline in skeletal muscle mass with aging is mainly attributed to a reduction in type II muscle fiber size , 2013, Experimental Gerontology.

[38]  M. Narici,et al.  Sarcopenia, Dynapenia, and the Impact of Advancing Age on Human Skeletal Muscle Size and Strength; a Quantitative Review , 2012, Front. Physio..

[39]  Norio Sugawara,et al.  Body composition in patients with schizophrenia: Comparison with healthy controls , 2012, Annals of General Psychiatry.

[40]  T. Scheewe,et al.  Lack of physical activity during leisure time contributes to an impaired health related quality of life in patients with schizophrenia , 2011, Schizophrenia Research.

[41]  R. Ganguli,et al.  Low cardiorespiratory fitness and physical functional capacity in obese patients with schizophrenia , 2011, Schizophrenia Research.

[42]  Hiroto Ito,et al.  Prevalence of diabetes and antipsychotic prescription patterns in patients with schizophrenia: A nationwide retrospective cohort study , 2010, Schizophrenia Research.

[43]  B. Clark,et al.  Functional consequences of sarcopenia and dynapenia in the elderly , 2010, Current opinion in clinical nutrition and metabolic care.

[44]  D. Vancampfort,et al.  Metabolic syndrome in people with schizophrenia: a review , 2009, World psychiatry : official journal of the World Psychiatric Association.

[45]  R. Ganguli,et al.  Increased caffeine and nicotine consumption in community-dwelling patients with schizophrenia , 2006, Schizophrenia Research.

[46]  W. Evans,et al.  Changes in Skeletal Muscle with Aging: Effects of Exercise Training , 1993, Exercise and sport sciences reviews.

[47]  K. Munz,et al.  TOTAL BODY WATER CONTENT IN NORMAL AND GROSSLY OBESE WOMEN , 1976, The Medical journal of Australia.